Literature DB >> 17607042

Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited.

Suhail A R Doi1, Nicholas J Woodhouse, Lukman Thalib, Adedayo Onitilo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17607042      PMCID： PMC1905932          DOI： 10.3121/cmr.2007.763

Source DB:  PubMed          Journal:  Clin Med Res        ISSN： 1539-4182


× No keyword cloud information.
  26 in total

1.  Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer.

Authors:  S A Doi; N J Woodhouse
Journal:  Clin Endocrinol (Oxf)       Date:  2000-06       Impact factor: 3.478

2.  Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer.

Authors:  K D McCowen; R A Adler; N Ghaed; T Verdon; F D Hofeldt
Journal:  Am J Med       Date:  1976-07       Impact factor: 4.965

3.  Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine: concise communication.

Authors:  C Ramacciotti; H T Pretorius; B R Line; J M Goldman; J Robbins
Journal:  J Nucl Med       Date:  1982-06       Impact factor: 10.057

4.  Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.

Authors:  C S Bal; Ajay Kumar; G S Pant
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

5.  Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer.

Authors:  Jamal Zidan; Elioz Hefer; Galina Iosilevski; Karen Drumea; Moshe E Stein; Abraham Kuten; Ora Israel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-08-01       Impact factor: 7.038

6.  Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy.

Authors:  Robbert B T Verkooijen; Marcel P M Stokkel; Jan W A Smit; Ernest K J Pauwels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

7.  High or low dose radioiodine ablation of thyroid remnants?

Authors:  H Creutzig
Journal:  Eur J Nucl Med       Date:  1987

8.  Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation.

Authors:  L J Degroot; M Reilly
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

9.  [Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer].

Authors:  M Gawkowska-Suwińska; M Turska; J Roskosz; Z Puch; B Jurecka-Tuleja; D Handkiewicz-Junak; Z Wygoda; B Jarzab
Journal:  Wiad Lek       Date:  2001

10.  Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.

Authors:  L Ramanna; A D Waxman; M B Brachman; D E Tanasescu; N Sensel; G D Braunstein
Journal:  Clin Nucl Med       Date:  1985-11       Impact factor: 7.794
View more
  10 in total

1.  Low versus high I-131 dose for remnant ablation in differentiated thyroid cancer.

Authors:  Allan Hackshaw; Ujjal Mallick
Journal:  Clin Med Res       Date:  2009-06

Review 2.  Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors:  Markus Luster; Theresia Weber; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

Review 3.  Radioiodine for remnant ablation and therapy of metastatic disease.

Authors:  Christoph Reiners; Heribert Hänscheid; Markus Luster; Michael Lassmann; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2011-08-09       Impact factor: 43.330

4.  Multiple Bone Metastases in a Patient with Differentiated Thyroid Cancer (DTC): Complete resolution following thyroidectomy and four ablation doses of I-131.

Authors:  Omayma T Elshafie; Samir Hussein; Aisha Al-Hamdani; Haddia Bererhi; Nicholas Jy Woodhouse
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

Review 5.  Radioiodine therapy for patients with differentiated thyroid cancer after thyroidectomy: direct comparison and network meta-analyses.

Authors:  Y Fang; Y Ding; Q Guo; J Xing; Y Long; Z Zong
Journal:  J Endocrinol Invest       Date:  2013-05-30       Impact factor: 4.256

6.  A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.

Authors:  T Ben Ghachem; I Yeddes; I Meddeb; A Bahloul; A Mhiri; I Slim; M F Ben Slimene
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-25       Impact factor: 2.503

7.  Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy.

Authors:  Syed Zubair Hussain; Maseeh Uz Zaman; Sarwar Malik; Nanik Ram; Ali Asghar; Unaib Rabbani; Nida Aftab; Najmul Islam
Journal:  J Thyroid Res       Date:  2014-04-09

8.  I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.

Authors:  Yan Shengguang; Choi Ji-Eun; He Li Lijuan
Journal:  Med Sci Monit       Date:  2016-07-13

9.  Association between the detection rate of thyroid cancer and the external radiation dose-rate after the nuclear power plant accidents in Fukushima, Japan.

Authors:  Hidehiko Yamamoto; Keiji Hayashi; Hagen Scherb
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

10.  Drug-induced liver injury caused by iodine-131.

Authors:  Chei Won Kim; Ji Sun Park; Se Hwan Oh; Jae-Hyung Park; Hyun-Ik Shim; Jae Woong Yoon; Jin Seok Park; Seong Bin Hong; Jun Mi Kim; Trong Binh Le; Jin Woo Lee
Journal:  Clin Mol Hepatol       Date:  2016-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.